Authors: WOLOSCHUK DMM RUBINGER M ISRAELS SJ HOUSTON DS SCHWETZ N JOHNSTON JB

Citation: Dmm. Woloschuk et al., IN-VITRO STABILITY OF PORCINE FACTOR-VIII (HYATE-C(R)), Haemophilia, 3(1), 1997, pp. 21-23

Authors: RUBINGER M HOUSTON DS SCHWETZ N WOLOSCHUK DMM ISRAELS SJ JOHNSTON JB

Citation: M. Rubinger et al., CONTINUOUS-INFUSION OF PORCINE FACTOR-VIII IN THE MANAGEMENT OF PATIENTS WITH FACTOR-VIII INHIBITORS, American journal of hematology, 56(2), 1997, pp. 112-118

Authors: RUBINGER M WOLOSCHUK DMM SCHWETZ N ISRAELS SJ HEINEMANN LC HOUSTON DS JOHNSTON JB

Citation: M. Rubinger et al., THE IN-VITRO STABILITY OF PORCINE FACTOR-VII (PFVIII) (HYATE-C) AND THE EFFICACY OF CONTINUOUS-INFUSION (CI) PFVIII IN THE TREATMENT OF PATIENTS WITH FVIII ANTIBODIES, Blood, 86(10), 1995, pp. 3532-3532

Authors: WOLOSCHUK DMM

Citation: Dmm. Woloschuk, DRUG PRECIPITATION AND PERISTALTIC PUMPS, American journal of hospital pharmacy, 51(11), 1994, pp. 1473-1473

Authors: GLENNIE JL WOLOSCHUK DMM HALL KW

Citation: Jl. Glennie et al., HIGH-TECHNOLOGY DRUGS FOR CANCER - THE DECISION-PROCESS FOR ADDING TOA FORMULARY, PharmacoEconomics, 4(6), 1993, pp. 405-413